Status:
RECRUITING
Tissue Collection for Drug Screening and Bioanalysis
Lead Sponsor:
Weill Medical College of Cornell University
Conditions:
Central Nervous System Tumor
Eligibility:
All Genders
Brief Summary
The purpose of this study is to improve upon the knowledge currently available about central nervous system (CNS) tumors. We will study the different characteristics of these tumors using tissue sampl...
Detailed Description
The goal of this project is to enable the acquisition of tissue available for research with the prospect of enabling the development of new therapeutic avenues for patients diagnosed with cancer in th...
Eligibility Criteria
Inclusion
- Inclusion Criteria for Tumor patients undergoing neurosurgery (cohort 1)
- Subject has presented with a suspected/confirmed neoplastic CNS lesion and is undergoing a neurosurgical procedure in which CNS tissue and/or tumors associated with this tissue will be removed.
- There must be tissue available in excess of that required by neuropathology for diagnostic purposes.
- Subject of all ages included.
- Subjects who are pregnant can be included.
- Subjects who are neonates (0-4 weeks) can be included.
- Inclusion Criteria for Non-tumor patients undergoing neurosurgery (cohort 2)
- Subject is between 4 weeks and 21 years of age and is undergoing a neurosurgical procedure at WCMC.
- Subject does not have a CNS tumor diagnosis.
- Subject should not be pregnant at the time of enrollment.
- Inclusion Criteria for Autopsy tumor tissue donation (cohort 3)
- Subject of all ages included
- Subject has been diagnosed with a neoplastic CNS lesion at the time of passing.
- Subjects who are pregnant can be included.
- Subjects who are neonates (0-4 weeks) can be included.
- Inclusion Criteria for parent of tumor patients
- Subject is the biological parent of a patient undergoing/ who underwent a neurosurgical procedure in which CNS tissue and/or tumors associated with this tissue will be/ was removed.
- Subject is the biological parent of patient enrolled in cohort 1.
- Subject is not pregnant at the time of enrollment.
Exclusion
Key Trial Info
Start Date :
July 22 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
July 22 2029
Estimated Enrollment :
500 Patients enrolled
Trial Details
Trial ID
NCT04852354
Start Date
July 22 2020
End Date
July 22 2029
Last Update
December 17 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Weill Cornell Medicine
New York, New York, United States, 10021